経皮大動脈弁植え込み術のグローバル市場2021-2028:経大腿、鎖骨下、大動脈直接

■ 英語タイトル:Percutaneous Aortic Valve Implantation Market by Procedure (Transfemoral, Subclavian, and Direct Aortic), End-user (Hospitals & Cardiac Centers and Ambulatory Surgical Center), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028

調査会社Research Dive社が発行したリサーチレポート(データ管理コード:RDV22AU044)■ 発行会社/調査会社:Research Dive
■ 商品コード:RDV22AU044
■ 発行日:2022年3月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:160
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single UserUSD5,700 ⇒換算¥843,600見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算¥1,287,600見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算¥1,583,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Research Dive社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[経皮大動脈弁植え込み術のグローバル市場2021-2028:経大腿、鎖骨下、大動脈直接]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Research Dive社の当調査資料では、世界の経皮大動脈弁植え込み術市場について多面的に分析し、調査手法、エグゼクティブサマリー、市場概要、処置別(経大腿、鎖骨下、大動脈直接)分析、エンドユーザー別(病院&心臓センター、外来手術センター)分析、地域別分析、企業情報などの内容をまとめております。なお、当書に掲載されている企業情報には、Boston Scientific Corporation、Abbott Laboratories、Becton Dickinson and Company、Bracco、Edwards Lifesciences Corporation、JenaValve Technology, Inc.、Venus Medtech、Medtronic Plc.、Meril Lifesciences、JC Medical Inc. などが含まれています。
・調査手法
・エグゼクティブサマリー
・市場概要
・世界の経皮大動脈弁植え込み術市場規模:処置別(経大腿、鎖骨下、大動脈直接)
・世界の経皮大動脈弁植え込み術市場規模:エンドユーザー別(病院&心臓センター、外来手術センター)
・世界の経皮大動脈弁植え込み術市場規模:地域別
・企業情報

According to Research Dive analysis, the global percutaneous aortic valve implantation market is estimated to generate a revenue of $13,454.6 million by 2028 increasing from $4,766.7 million in 2020, at a healthy CAGR of 13.9%.

Impact Analysis of COVID-19 on the Global Percutaneous Aortic Valve Implantation Market:
The global percutaneous aortic valve implantation market experienced a low growth rate during the COVID-19 pandemic. Due to strict lockdown rules by government bodies of countries across the globe, non-essential hospital facilities were fully closed. Also, most of the medical device companies are facing revenue losses due to higher cost of supply chain which decreased the global percutaneous aortic valve implantation demand.

Percutaneous Aortic Valve Implantation Market Analysis:
The global percutaneous aortic valve implantation market experienced an appreciable growth due to adoption of unhealthy lifestyle choices and rising in new products approvals in the field of percutaneous aortic valve implantation. Moreover, growing population with cardiovascular diseases influenced the market growth. All such types of factors may lead to a surge in the demand for percutaneous aortic valve implantation and market growth during the analysis frame.
High cost of percutaneous aortic valve implantation and lack of knowledge about how to use percutaneous aortic valve implantation might be restricting factors which may create a negative impact on the market during the forecast period.
The percutaneous aortic valve implantation industry is growing rapidly owing to increasing rising in geriatric population along with favorable reimbursement plans for mediclaim plans, Medicare and insurance claims sponsored by the government regulatory authorities are some of the elements that may increase the growth of the sector during the forecast period.

Based on procedure, the global market for percutaneous aortic valve implantation is divided into transfemoral, subclavian, and direct aortic. The transfemoral type sub-segment is predicted to have the fastest growth as well as be the dominant market share and generate a revenue of $8,422.6 million by 2028.
Based on end-user, the market is classified into hospitals & cardiac centers and ambulatory surgical center. The hospitals & cardiac centers sub-segment garnered $2,974.4 million in 2020 and is projected to grow exponentially by 2028.
Based on geographical scope, the market was investigated across North America, Europe, Asia-Pacific, and LAMEA. The Asia-Pacific percutaneous aortic valve implantation market is anticipated to rise at a growth rate of 14.7% by 2028 from the revenue generated in 2020.

The companies involved in the global percutaneous aortic valve implantation market are Boston Scientific Corporation, Abbott Laboratories, Becton Dickinson and Company, Bracco, Edwards Lifesciences Corporation, JenaValve Technology, Inc., Venus Medtech, Medtronic Plc., Meril Lifesciences, and JC Medical Inc.

*** レポート目次(コンテンツ)***

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters

1.4.1.Assumptions
1.4.2.Forecast parameters

1.5.Data sources

1.5.1.Primary
1.5.2.Secondary

2.Executive Summary

2.1.360° summary
2.2.By Procedure trends
2.3.By End-User trends

3.Market overview

3.1.Market segmentation & definitions
3.2.Key takeaways

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis

3.3.1.Bargaining power of consumers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Competitive rivalry in the market

3.4.Market dynamics

3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities

3.5.Technology landscape
3.6.Regulatory landscape
3.7.Patent landscape
3.8.Market value chain analysis

3.8.1.Stress point analysis
3.8.2.Raw material analysis
3.8.3.Manufacturing process
3.8.4.Sales Channel analysis
3.8.5.Operating vendors

3.8.5.1.Raw material suppliers
3.8.5.2.Procedure manufacturers
3.8.5.3.Procedure distributors

3.9.Strategic overview

4.Percutaneous Aortic Valve Implantation Market, by Procedure

4.1.Overview

4.1.1.Market size and forecast, by Procedure

4.2.Transfemoral

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region, 2020-2028
4.2.3.Market share analysis, by country 2020 & 2028

4.3.Subclavian

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region, 2020-2028
4.3.3.Market share analysis, by country 2020 & 2028

4.4.Direct aortic

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region, 2020-2028
4.4.3.Market share analysis, by country 2020 & 2028

5.Percutaneous Aortic Valve Implantation Market, by End-User

5.1.Overview

5.1.1.Market size and forecast, by Sales Channel

5.2.Hospitals and Cardiac Centers

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region, 2020-2028
5.2.3.Market share analysis, by country 2020 & 2028

5.3.Ambulatory Surgical Center

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region, 2020-2028
5.3.3.Market share analysis, by country 2020 & 2028

6.Percutaneous Aortic Valve Implantation Market, by Region

6.1.Overview

6.1.1.Market size and forecast, by region

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by Procedure , 2020-2028
6.2.3.Market size and forecast, by End-User , 2020-2028
6.2.4.Market size and forecast, by country, 2020-2028

6.2.5.U.S.

6.2.5.1.Market size and forecast, by Procedure , 2020-2028
6.2.6.Market size and forecast, by End-User , 2020-2028

6.2.7.Canada

6.2.7.1.Market size and forecast, by Procedure , 2020-2028
6.2.8.Market size and forecast, by End-User , 2020-2028

6.2.9.Mexico

6.2.10.Market size and forecast, by End-User , 2020-2028

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by Procedure , 2020-2028
6.3.3.Market size and forecast, by End-User , 2020-2028
6.3.4.Market size and forecast, by country, 2020-2028

6.3.5.Germany

6.3.5.1.Market size and forecast, by Procedure , 2020-2028
6.3.6.Market size and forecast, by End-User , 2020-2028

6.3.7.UK

6.3.7.1.Market size and forecast, by Procedure, 2020-2028
6.3.7.2.Market size and forecast, by End-User, 2020-2028

6.3.8.France

6.3.8.1.Market size and forecast, by Procedure, 2020-2028
6.3.8.2.Market size and forecast, by End-User, 2020-2028

6.3.9.Spain

6.3.9.1.Market size and forecast, by Procedure 2020-2028
6.3.9.2.Market size and forecast, by End-User, 2020-2028

6.3.10.Italy

6.3.10.1.Market size and forecast, by Procedure , 2020-2028
6.3.10.2.Market size and forecast, by End-User, 2020-2028

6.3.11.Rest of Europe

6.3.11.1.Market size and forecast, by Procedure , 2020-2028
6.3.11.2.Market size and forecast, by End-User , 2020-2028

6.4.Asia Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by Procedure , 2020-2028
6.4.3.Market size and forecast, by End-User , 2020-2028
6.4.4.Market size and forecast, by country, 2020-2028

6.4.5.China

6.4.5.1.Market size and forecast, by Procedure , 2020-2028
6.4.5.2.Market size and forecast, by End-User , 2020-2028

6.4.6.Japan

6.4.6.1.Market size and forecast, by Procedure , 2020-2028
6.4.6.2.Market size and forecast, by End-User , 2020-2028

6.4.7.India

6.4.7.1.Market size and forecast, by Procedure , 2020-2028
6.4.7.2.Market size and forecast, by End-User , 2020-2028

6.4.8.South Korea

6.4.8.1.Market size and forecast, by Procedure , 2020-2028
6.4.8.2.Market size and forecast, by End-User , 2020-2028

6.4.9.Australia

6.4.9.1.Market size and forecast, by Procedure , 2020 2028
6.4.9.2.Market size and forecast, by End-User , 2020-2028
6.4.9.3.Comparative market share analysis, 2020 & 2028

6.4.10.Rest of Asia Pacific

6.4.10.1.Market size and forecast, by Procedure , 2020-2028
6.4.10.2.Market size and forecast, by End-User , 2020-2028

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by Procedure , 2020-2028
6.5.2.1.Market size and forecast, by End-User , 2020-2028
6.5.3.Market size and forecast, by country, 2020-2028

6.5.4.Latin America

6.5.4.1.Market size and forecast, by Procedure , 2020-2028
6.5.4.2.Market size and forecast, by End-User , 2020-2028

6.5.5.Middle East

6.5.5.1.Market size and forecast, by Procedure , 2020-2028
6.5.5.2.Market size and forecast, by End-User , 2020-2028

6.5.6.Africa

6.5.6.1.Market size and forecast, by Procedure , 2020-2028
6.5.6.2.Market size and forecast, by End-User , 2020-2028

7.Company profiles

7.1. Boston Scientific Corporation

7.1.1.Company overview
7.1.2.Operating business segments
7.1.3.Procedure portfolio
7.1.4.Financial Performance
7.1.5.Recent strategic moves & developments

7.2. Abbott Laboratories

7.2.1.Company overview
7.2.2.Operating business segments
7.2.3.Procedure portfolio
7.2.4.Financial Performance
7.2.5.Recent strategic moves & developments

7.3.Becton Dickinson and Company

7.3.1.Company overview
7.3.2.Operating business segments
7.3.3.Procedure portfolio
7.3.4.Financial Performance
7.3.5.Recent strategic moves & developments

7.4.Bracco

7.4.1.Company overview
7.4.2.Operating business segments
7.4.3.Procedure portfolio
7.4.4.Financial Performance
7.4.5.Recent strategic moves & developments

7.5.Edwards Lifesciences Corporation

7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Procedure portfolio
7.5.4.Financial Performance
7.5.5.Recent strategic moves & developments

7.6.JenaValve Techologies Inc.,

7.6.1.Company overview
7.6.2.Operating business segments
7.6.3.Procedure portfolio
7.6.4.Financial Performance
7.6.5.Recent strategic moves & developments

7.7.Venus Medtech

7.7.1.Company overview
7.7.2.Operating business segments
7.7.3.Procedure portfolio
7.7.4.Financial Performance
7.7.5.Recent strategic moves & developments

7.8. Medtronic Plc.,

7.8.1.Company overview
7.8.2.Operating business segments
7.8.3.Procedure portfolio
7.8.4.Financial Performance
7.8.5.Recent strategic moves & developments
7.9.Meril Lifesciences

7.9.1.Company overview

7.9.2.Operating business segments
7.9.3.Procedure portfolio
7.9.4.Financial Performance
7.9.5.Recent strategic moves & developments

7.10.JC Medical Inc.

7.10.1.Company overview
7.10.2.Operating business segments
7.10.3.Procedure portfolio
7.10.4.Financial Performance
7.10.5.Recent strategic moves & developments



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(RDV22AU044 )"経皮大動脈弁植え込み術のグローバル市場2021-2028:経大腿、鎖骨下、大動脈直接" (英文:Percutaneous Aortic Valve Implantation Market by Procedure (Transfemoral, Subclavian, and Direct Aortic), End-user (Hospitals & Cardiac Centers and Ambulatory Surgical Center), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028)はResearch Dive社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。